slides · global inventory
Chart Selection Guide
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 8,343
Current window 6,181-6,210
Pages 279
Rows per page 30
Tool
6,181-6,210 of 8,343
11
The chart is a screenshot of the Freightos Baltic Index (FBX11) dashboard.Freightos | Results Presentation Deck | 22 slides · Freightos
Conference presentation Investor relations 1 hit
12
The chart displays a significant dip in early 2020 followed by a recovery and subsequent volatility.Freightos | Results Presentation Deck | 22 slides · Freightos
Conference presentation Investor relations 1 hit
13
The slide is a screenshot of a digital dashboard interface.Freightos | Results Presentation Deck | 22 slides · Freightos
Conference presentation Investor relations 1 hit
14
The chart displays three data series: Asia-Americas (Northern), Asia-Europe, and Europe-Americas (Northern).Freightos | Results Presentation Deck | 22 slides · Freightos
Conference presentation Investor relations 1 hit
28
The slide uses two line charts with error bars to demonstrate the therapeutic index improvement of the cold+hot regimen.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
12
Grove | Investor Presentation Deck | 41 slidesGrove | Investor Presentation Deck | 41 slides · Grove Collaborative
Pitch deck Investor relations Beat · Rising SuccessLoop · Why Now1 hit
29
The slide uses a combination of a bar chart for absolute dollar values and a line chart for the PTPP/Average assets ratio.Hanmi Financial | Results Presentation Deck | 47 slides · Hanmi Financial
Conference presentation Investor relations Beat · Financials1 hit
36
Includes footnotes detailing composition of liquid assets and debt terms.Hanmi Financial | Results Presentation Deck | 47 slides · Hanmi Financial
Conference presentation Investor relations Beat · Financials1 hit
12
The slide details two main pillars of optimization: charter consolidation and operational/branch efficiency.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
10
The slide uses a series of horizontal bar charts to demonstrate market leadership in deal counts.Houlihan Lokey | Investor Presentation Deck | 33 slides · Houlihan Lokey
Pitch deck Investor relations Beat · Market Size1 hit
16
The chart uses a waterfall-bridge style to show the growth from the initial 2025 ambition of €4.0B to the new ambition of €5.0B.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
20
The slide uses a combination of bar charts and a process flow to illustrate growth and efficiency targets.Hugo Boss | Investor Day Presentation Deck | 107 slides · Hugo Boss
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
14
Includes a disclaimer about 2023 figures representing guidance midpoints.Hyperfine | Investor Presentation Deck | 16 slides · Hyperfine
Pitch deck Investor relations Beat · Financial ProfileLoop · Quick Win Big Bet1 hit
05
The slide highlights NXC-201's superior efficacy (100% response rate) and safety profile (zero neurotoxicity) compared to existing therapies.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
08
The slide explicitly warns about cross-trial comparison limitations in the footer.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations Beat · Problem1 hit
36
The slide uses a bubble chart to map mPFS against patient treatment history and a table to detail clinical outcomes across lines of therapy.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
42
Includes technical diagrams of the drug construct, comparative histology, and survival curves.Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
44
The slide uses a two-part structure: clinical efficacy (top right) and mechanism of action (bottom right).Immix Biopharma | Investor Presentation Deck | 52 slides · Immix Biopharma
Pitch deck Investor relations 1 hit
12
The chart uses a dual-axis approach: stacked bars for loss amounts ($Billions) and a line graph for the Combined Ratio (%).International General Insurance | Results Presentation Deck | 20 slides · International General Insurance
Conference presentation Investor relations Beat · Financial Performance OverviewLoop · Cost Of Inaction1 hit
15
Includes footnotes regarding non-PC revenue and non-HKFRS measures.Lenovo | Results Presentation Deck | 29 slides · Lenovo
Conference presentation Investor relations Beat · SatisfactionLoop · Cost Of Inaction1 hit
19
Includes a footnote regarding non-IFRS measures.Lion Electric | Investor Presentation Deck | 32 slides · Lion Electric
Pitch deck Investor relations Beat · Financials1 hit
19
The chart shows a significant dip in Q1 2022 EBIT, likely an outlier or specific accounting event.Maersk | Results Presentation Deck | 33 slides · Maersk
Conference presentation Investor relations 1 hit
13
The slide uses dot plots for IC50 data and a bar chart for tumor regression efficacy.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
34
Includes three distinct charts: a dot plot for IC50, a bar chart for selectivity index, and a bar chart for brain penetrance.Nuvalent | Investor Presentation Deck | 39 slides · Nuvalent
Pitch deck Investor relations 1 hit
18
The charts demonstrate efficacy in specific cell lines (KYSE70 and Cal27) with known genetic alterations.Nuvectis Pharma | Investor Presentation Deck | 23 slides · Nuvectis Pharma
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a combination of bullet points, a comparison table, and a bar chart to build a market opportunity case.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
19
The slide uses a hybrid layout combining a gallery of antibody structural diagrams with a pie chart representing market/clinical distribution.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
The chart shows a clear upward trend in partner patent filings from 2014 to 2022.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide highlights the shift toward recurring revenue models.Omnicell | Investor Presentation Deck | 27 slides · Omnicell
Pitch deck Investor relations Beat · Business Model1 hit
07
Includes footnotes explaining non-GAAP measures and specific adjustments.Paysafe | Results Presentation Deck | 21 slides · Paysafe
Conference presentation Investor relations Beat · Financials1 hit